⌘K
t
Hikma Pharmaceuticals PLC submitted a Block Listing Six Monthly Return on 1 October 2024. During the period from 1 April 2024 to 30 September 2024, the company allotted 1,194 Ordinary Shares of 10 pence under its 2018 Management Incentive Plan. This resulted in a balance of 311,430 unallotted Ordinary Shares of 10 pence under the combined 2018 Management Incentive Plan and 2014 Executive Incentive Plan as of 30 September 2024.
| Date | 1 Oct 2024 |
| Time | 09:45:02 |
| Category | Capital structure |
| ID | 4469G |
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 1 October 2024
|
Name of applicant: |
Hikma Pharmaceuticals PLC |
||
|
Name of scheme: |
Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans") |
||
|
Period of return |
From: 1 April 2024 |
To: |
30 September 2024 |
|
Balance of unallotted securities under scheme(s) from previous return: |
The Plans: 312,624 Ordinary Shares of 10 pence |
||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
The Plans: 0 Ordinary Shares of 10 pence |
||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
MIP: 1,194 Ordinary Shares of 10 pence EIP: 0 Ordinary Shares of 10 pence |
||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
The Plans: 311,430 Ordinary Shares of 10 pence |
||
|
Name of contact: |
Helen Middlemist |
|
Telephone number of contact: |
+44(0)20 7399 2760 |
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI: 549300BNS685UXH4JI75)